Quest Diagnostics, Inc. (DGX) Company Profile & Statistics

Quest Diagnostics, Inc.
DGX
(NYSE)
Closed
163.86
+2.54 (+1.57%)
in:usd•As of: Nov 21, 2024 15:59 UTC -5
Open
160.64
High
164.25
Low
160.33

About Quest Diagnostics, Inc.

CEO

James E. Davis

Headquarters

500 plaza drive

secaucus, nj 07094, united states

Auditor

PricewaterhouseCoopers LLP

Employees

48,000

Share Holders

2,110

Website

http://www.questdiagnostics.com

Industry

servicestothe health industry

Sector

health services

Company Overview

Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.

Quest Diagnostics, Inc. Statistics

Valuation Measures

Market Capitalization ²	18.29B
Enterprise Value	23.78B
Enterprise Value/EBITDA (ttm)	13.83
Price to Earnings Ratio (ttm)	18.23
Price to Book (mrq)	2.63
Price to Sales (ttm)	1.89
Price to Cash (ytd)	12.65

Profitability

Gross Margin (ttm)	32.72%
Operating Margin (ttm)	10.52%
Profit Margin (ttm)	8.78%
Return on Equity (ttm)	15.25%
Return on Invested Capital (ttm)	8.12%
Return on Assets (ttm)	6.92%

Income Statement

Revenue (ttm)	9.54B
Revenue Per Share (ttm)	85.46
Gross Profit (ttm)	3.12B
EBITDA (ttm)³	1.72B
Net Income Avi to Common (ttm)	838.00M
Diluted EPS (ttm)	7.44

Share Statistics

Beta (5Y Monthly)	0.89
52-Week Change	24.13%
S&P500 52-Week Change	30.55%
S&P500 Member	Yes
Stock Optionable	Yes
Total Shares Outstanding ¹	111.62M
Dividend Yield	1.86%
Float ⁴	110.73M
% Held by Insiders	0.79%
% Held by Institutions	88.06%

Balance Sheet

Total Cash (mrq)	764.00M
Total Cash Per Share (mrq)	6.84
Total Debt (mrq)	6.25B
Total Debt/Equity (mrq)	91.38%
Current Ratio (mrq)	1.25%
Quick Ratio (mrq)	1.17%
Book Value Per Share (mrq)	61.08

Cash Flow

Operating Cash Flow Per Share (ytd)	7.70
Free Cash Flow (ytd)	568.00M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Quest Diagnostics, Inc.

Trade With A Regulated Broker